日本全国性机器人远端胰腺癌切除术的实施与围术期结局:倾向性评分匹配分析
基于日本国家临床数据库2019—2023年12124例恶性疾病远端胰腺切除术数据,经倾向性评分匹配比较机器人、开腹与腹腔镜手术。机器人对比开腹:Clavien-Dindo≥III级并发症(15.5% vs 18.5%;机器人对比腹腔镜:中转率更低(2.6% vs 6.6%;
要点
- 机器人远端胰腺切除术已在日本全国安全实施,但相比腹腔镜优势有限。
- 机器人对比开腹可减少出血、缩短住院,但30天再入院更高。
- 机器人对比腹腔镜主要优势在于降低中转率和减少术中出血。
核心结论
- 机器人远端胰腺切除术已在日本全国范围安全实施,但其相对于腹腔镜的优势似乎有限,明确获益主要在于降低中转率和减少术中出血。
研究设计与样本
- 基于日本国家临床数据库(覆盖全国>95%手术)的回顾性队列研究,纳入2019—2023年因恶性疾病行远端胰腺切除术的患者12124例,采用倾向性评分匹配比较机器人、开腹与腹腔镜手术。
- 匹配后分析机器人-开腹配对921对、机器人-腹腔镜配对920对。
主要发现
- 深静脉血栓在机器人对比开腹和机器人对比腹腔镜中均更常见。
临床怎么用
- 机器人远端胰腺切除术可安全用于恶性疾病,但选择时需权衡其相对于腹腔镜的有限优势(主要降低中转和出血)与更长手术时间及深静脉血栓风险。
- 推广前需进一步评估肿瘤学结局和经济性。
局限性
- 本研究为回顾性数据库分析,可能存在未测量混杂。
- 未报告肿瘤学结局(如切缘状态、淋巴结清扫数目、生存)和经济性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Minimally invasive distal pancreatectomy (DP) leads to improved recovery compared with open DP; however, robotic DP recovery data are limited, based on small, expert-center studies. We aimed to compare perioperative outcomes of robotic, open, and laparoscopic DP for malignant disease in a nationwide cohort within a nationally credentialed implementation program. METHODS: Japanese National Clinical Database data were obtained, capturing >95% of all surgical procedures performed nationwide. Patients who underwent DP between 2019 and 2023 were identified, and outcomes of robotic, open, and laparoscopic DP were compared using propensity score matching. RESULTS: Among 12,124 DPs, 921 robotic-open and 920 robotic-laparoscopic matched pairs were analyzed. Compared with open DP, robotic DP showed a trend toward lower rates of overall Clavien-Dindo ≥ III complications (15.5% vs 18.5%; P = .09) and clinically relevant pancreatic fistula (16.9% vs 20.2%; P = .07), with reduced blood loss (67 vs 280 mL; P < .001) and longer operative time. Hospital stay was shorter; however, 30-day readmission was higher for robotic DP. Compared with laparoscopic DP, robotic DP exhibited lower conversion (2.6% vs 6.6%; P < .001), reduced blood loss (66 vs 100 mL; P < .001), longer operative time, comparable morbidity, and marginally shorter hospitalization periods. Deep venous thrombosis occurred more frequently after robotic DP in both comparisons. CONCLUSION: While robotic DP has been safely implemented nationwide, its advantages over laparoscopic DP appear limited, with clear benefits primarily in conversion reduction and reduced intraoperative blood loss. To justify its broader clinical adoption, evaluation of oncologic outcomes and economic implications is warranted.
引用
- Ikenaga N, Kumamaru H, Inomata M, et al. Nationwide implementation and perioperative outcomes of robotic distal pancreatectomy for malignancy: A propensity score matched analysis in Japan. Surgery. 2026. PMID: 42275914. doi:10.1016/j.surg.2026.110324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。